The inhibitory activities of known microcins were evaluated against some diarrheagenic Escherichia coli strains. Some antibacterial properties of microcin J25, the most active one, were studied. A rapid two-step purification was performed. The MIC and the minimum bactericidal concentration of J25 against E. coli O157:H7 were 1 and 100 g ml ؊1 , respectively. A 10 4 -CFU ml ؊1 contamination by this strain was destroyed in milk and meat extract by 6.25 g of J25 ml
103.571 (respective serotypes: O111:H12, O55:H6, O26:H11, O119, O125, and O157:H7) and nine clinical isolates obtained from different patients with acute diarrhea, which were serotypes O26, O55 (three strains), O86, and O111 and three undetermined serotypes (X 1 , X 2 , and X 3 ).
Brain heart infusion (BHI), Mueller-Hinton broth, nutrient broth (NB), and bacteriological products were purchased from Biokar Diagnostics (Beauvais, France). M63 minimal medium was prepared as described by Miller (11) and supplemented with glucose (0.2%), thiamine (0.01%), and Casamino Acids (0.1%). The media for plating were solidified with 12 or 6 g of E-type agar (soft agar) liter
Ϫ1
. Unless otherwise stated, bacterial cultures were propagated in BHI at 37°C. Working cultures were maintained at 4°C on BHI agar slants. Stock cultures were stored at Ϫ80°C.
Inhibition assays. M63 agar (10 ml) was overlaid with 5 ml of M63 soft agar seeded with 10 7 CFU of the target strain ml Ϫ1 . Sterile glass rings (4-mm inside diameter [i.d.]) were placed on the soft agar and filled with 20 l of filter-sterilized samples to be tested. The plates were incubated for 24 h at 37°C and clear inhibition zones were measured. Inhibition assays were done in triplicate. The results of the inhibition of DEC strains by culture supernatants of microcin producer strains are given in Table 1 . No strain was resistant to all the microcins, but the strains showed various sensitivities to the microcins.
It also appeared that each microcin had a different spectrum of activity. Under our experimental conditions, Col V was the most ineffective product. On the other hand, J25, which had inhibitory activity against 12 of the 15 DEC strains (including all the clinical isolates), was apparently the most active one. Thus, we purified it and carried out further studies of some of its growth-inhibiting properties.
Purification of microcin J25 and analysis of its antagonistic properties against DEC. A culture (18 h, 37°C) of the J25 producer in M63 medium was centrifuged (13,000 ϫ g, 30 min, 10°C) and heated (10 min, 120°C). Crude extract was prepared from heated supernatant by ammonium sulfate precipitation (95% saturation). The pellet was resuspended in water (1/80 of the initial culture volume) and dialyzed (with a membrane cutoff of 1,000) against water (24 h, 10°C). The crude microcin was then purified by reversed-phase high-pressure liquid chromatography (RP-HPLC). Filtered samples (2 ml) were subjected to semipreparative RP-HPLC (Delta Pak C 18 . The MIC was determined by the standard broth macrodilution method as described by Sahm and Washington (14) . We checked that the highest concentration of acetonitrile in Mueller-Hinton broth was not affecting the growth of tested bacteria. The minimum bactericidal concentration (MBC) was determined from tubes showing complete inhibition. An NB agar plate was seeded on the surface with 0.1 ml from each clear tube and incubated (24 h, 37°C). The MBC was defined as the lowest concentration in the tubes giving no growth on an NB plate afterwards.
The results of the inhibition assays for DEC strains with J25 p are reported in Table 2 . This microcin inhibited all the DEC strains tested with varying effectiveness. Most of the strains (11 of 15) had high sensitivities to J25 p (inhibition zones were Ͼ20 mm with 2 g of drug), clinical isolate O86 showed medium sensitivity to J25 p , and 3 strains displayed low sensitivities to J25 p (inhibition zones were obtained only with 20 g of drug). Microcin J25 p inhibited the growth of E. coli O157:H7 in a dose-dependent manner with 1 to 1,000 g ml Ϫ1 (results not shown). With the same target strain, the MIC and the MBC of J25 p were 1 and 100 g ml
, respectively. Ability of microcin J25 to inhibit E. coli O157:H7 in biological products. The inhibition activity of J25 p against E. coli O157:H7 was tested in three products: sterile skim milk, diluted egg yolk (1:1 mixture of sterile egg yolk and sterile water), and meat extract (50 g of sterile water was added to 100 g of mincemeat and mixed for 5 min in a stomacher at maximum speed; the supernatant was harvested by centrifugation and then filter sterilized before use). Product samples of 500 l mixed with 20 l of an appropriate dilution of the initial J25 p solution in sterile saline water (8.5 g liter Ϫ1 ) were inoculated with 5 l of an E. coli O157:H7 culture in M63 medium (12 h, 37°C) diluted with sterile M63 medium in order to obtain the desired quantity of cells. After 24 h of incubation (37°C), the presence of viable cells in 100-l samples was checked using a spiral plating method on BHI agar with incubation (37°C, 24 h). Assays were done three times.
When the three products contained 6.25 g of J25 p ml
and an E. coli O157:H7 concentration of 10 3 CFU ml
, no viable bacteria were detected after 24 h (0 CFU in three 100-l product samples). With an O157:H7 concentration of 10 4 CFU ml Ϫ1 , we obtained the same results (i.e., no bacteria were detected) in milk and meat extract, but complete inhibition required 50 g of J25 p ml Ϫ1 in egg yolk, due to the richness of the medium.
The data presented here show the possibility of using microcins to control DEC strains, including serotype O157:H7.
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